4cjn - Revision history

OCA at 12:11, 20 December 2023

OCA — Wed, 20 Dec 2023 12:11:19 GMT

←Older revision		Revision as of 12:11, 20 December 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4cjn]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Staphylococcus_aureus_subsp._aureus_Mu50 Staphylococcus aureus subsp. aureus Mu50]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CJN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CJN FirstGlance]. <br>		<table><tr><td colspan='2'>[[4cjn]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Staphylococcus_aureus_subsp._aureus_Mu50 Staphylococcus aureus subsp. aureus Mu50]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CJN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CJN FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MUR:MURAMIC+ACID'>MUR</scene>, <scene name='pdbligand=QNZ:(E)-3-(2-(4-CYANOSTYRYL)-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC+ACID'>QNZ</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.947Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MUR:MURAMIC+ACID'>MUR</scene>, <scene name='pdbligand=QNZ:(E)-3-(2-(4-CYANOSTYRYL)-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC+ACID'>QNZ</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cjn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cjn OCA], [https://pdbe.org/4cjn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cjn RCSB], [https://www.ebi.ac.uk/pdbsum/4cjn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cjn ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cjn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cjn OCA], [https://pdbe.org/4cjn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cjn RCSB], [https://www.ebi.ac.uk/pdbsum/4cjn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cjn ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
-	[[https://www.uniprot.org/uniprot/A0A0J9X1X5_STAAM A0A0J9X1X5_STAAM]]	+	[https://www.uniprot.org/uniprot/A0A0J9X1X5_STAAM A0A0J9X1X5_STAAM]
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==

OCA at 07:18, 14 September 2022

OCA — Wed, 14 Sep 2022 07:18:30 GMT

←Older revision		Revision as of 07:18, 14 September 2022
Line 3:		Line 3:
	<StructureSection load='4cjn' size='340' side='right'caption='[[4cjn]], [[Resolution\|resolution]] 1.95Å' scene=''>		<StructureSection load='4cjn' size='340' side='right'caption='[[4cjn]], [[Resolution\|resolution]] 1.95Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4cjn]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Staam Staam~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CJN OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4CJN FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4cjn]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Staphylococcus_aureus_subsp._aureus_Mu50 Staphylococcus aureus subsp. aureus Mu50]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CJN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CJN FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MUR:MURAMIC+ACID'>MUR</scene>, <scene name='pdbligand=QNZ:(E)-3-(2-(4-CYANOSTYRYL)-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC+ACID'>QNZ</scene~~></td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MUR:MURAMIC+ACID'>MUR</scene>, <scene name='pdbligand=QNZ:(E)-3-(2-(4-CYANOSTYRYL)-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC+ACID'>QNZ</scene></td></tr>
-	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Serine-type_D-Ala-D-Ala_carboxypeptidase Serine-type D-Ala-D-Ala carboxypeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.16.4 3.4.16.4] </span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cjn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cjn OCA], [https://pdbe.org/4cjn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cjn RCSB], [https://www.ebi.ac.uk/pdbsum/4cjn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cjn ProSAT]</span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4cjn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cjn OCA], [~~http~~://pdbe.org/4cjn PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4cjn RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4cjn PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4cjn ProSAT]</span></td></tr>	+
	</table>		</table>
		+	== Function ==
		+	[[https://www.uniprot.org/uniprot/A0A0J9X1X5_STAAM A0A0J9X1X5_STAAM]]
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 19:		Line 20:

	==See Also==		==See Also==
-	*[[Penicillin-binding protein\|Penicillin-binding protein]]	+	*[[Penicillin-binding protein 3D structures\|Penicillin-binding protein 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
Line 25:		Line 26:
	</StructureSection>		</StructureSection>
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Serine-type D-Ala-D-Ala carboxypeptidase]]~~	+	[[Category: Staphylococcus aureus subsp. aureus Mu50]]
-	~~[[Category: Staam~~]]	+	[[Category: Bouley R]]
-	[[Category: Bouley, R]]	+	[[Category: Hermoso JA]]
-	[[Category: Hermoso~~, J A~~]]	+	[[Category: Otero LH]]
-	[[Category: Otero~~, L H~~]]	+	[[Category: Rojas-Altuve A]]
-	[[Category: Rojas-Altuve, A]]	+
-	~~[[Category: Allosteric site]]~~	+
-	~~[[Category: Hydrolase]]~~	+
-	~~[[Category: Immune system~~]]	+

OCA at 10:01, 20 March 2019

OCA — Wed, 20 Mar 2019 10:01:16 GMT

←Older revision		Revision as of 10:01, 20 March 2019
Line 1:		Line 1:

	==Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand==		==Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand==
-	<StructureSection load='4cjn' size='340' side='right' caption='[[4cjn]], [[Resolution\|resolution]] 1.95Å' scene=''>	+	<StructureSection load='4cjn' size='340' side='right'caption='[[4cjn]], [[Resolution\|resolution]] 1.95Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4cjn]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CJN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CJN FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4cjn]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Staam Staam]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CJN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CJN FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MUR:MURAMIC+ACID'>MUR</scene>, <scene name='pdbligand=QNZ:(E)-3-(2-(4-CYANOSTYRYL)-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC+ACID'>QNZ</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MUR:MURAMIC+ACID'>MUR</scene>, <scene name='pdbligand=QNZ:(E)-3-(2-(4-CYANOSTYRYL)-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC+ACID'>QNZ</scene></td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Serine-type_D-Ala-D-Ala_carboxypeptidase Serine-type D-Ala-D-Ala carboxypeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.16.4 3.4.16.4] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Serine-type_D-Ala-D-Ala_carboxypeptidase Serine-type D-Ala-D-Ala carboxypeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.16.4 3.4.16.4] </span></td></tr>
Line 17:		Line 17:
	</div>		</div>
	<div class="pdbe-citations 4cjn" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 4cjn" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Penicillin-binding protein\|Penicillin-binding protein]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Serine-type D-Ala-D-Ala carboxypeptidase]]		[[Category: Serine-type D-Ala-D-Ala carboxypeptidase]]
		+	[[Category: Staam]]
	[[Category: Bouley, R]]		[[Category: Bouley, R]]
	[[Category: Hermoso, J A]]		[[Category: Hermoso, J A]]

OCA at 20:08, 15 December 2016

OCA — Thu, 15 Dec 2016 20:08:25 GMT

←Older revision		Revision as of 20:08, 15 December 2016
Line 1:		Line 1:
		+
	==Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand==		==Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand==
	<StructureSection load='4cjn' size='340' side='right' caption='[[4cjn]], [[Resolution\|resolution]] 1.95Å' scene=''>		<StructureSection load='4cjn' size='340' side='right' caption='[[4cjn]], [[Resolution\|resolution]] 1.95Å' scene=''>
Line 5:		Line 6:
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MUR:MURAMIC+ACID'>MUR</scene>, <scene name='pdbligand=QNZ:(E)-3-(2-(4-CYANOSTYRYL)-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC+ACID'>QNZ</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MUR:MURAMIC+ACID'>MUR</scene>, <scene name='pdbligand=QNZ:(E)-3-(2-(4-CYANOSTYRYL)-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC+ACID'>QNZ</scene></td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Serine-type_D-Ala-D-Ala_carboxypeptidase Serine-type D-Ala-D-Ala carboxypeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.16.4 3.4.16.4] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Serine-type_D-Ala-D-Ala_carboxypeptidase Serine-type D-Ala-D-Ala carboxypeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.16.4 3.4.16.4] </span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cjn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cjn OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4cjn RCSB], [http://www.ebi.ac.uk/pdbsum/4cjn PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cjn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cjn OCA], [http://pdbe.org/4cjn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4cjn RCSB], [http://www.ebi.ac.uk/pdbsum/4cjn PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4cjn ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 15:		Line 16:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4cjn" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 11:54, 12 February 2015

OCA — Thu, 12 Feb 2015 11:54:49 GMT

←Older revision		Revision as of 11:54, 12 February 2015
Line 1:		Line 1:
-	'''~~Unreleased~~ structure'''	+	==Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand==
		+	<StructureSection load='4cjn' size='340' side='right' caption='[[4cjn]], [[Resolution\|resolution]] 1.95Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[4cjn]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CJN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CJN FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MUR:MURAMIC+ACID'>MUR</scene>, <scene name='pdbligand=QNZ:(E)-3-(2-(4-CYANOSTYRYL)-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC+ACID'>QNZ</scene></td></tr>
		+	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Serine-type_D-Ala-D-Ala_carboxypeptidase Serine-type D-Ala-D-Ala carboxypeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.16.4 3.4.16.4] </span></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cjn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cjn OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4cjn RCSB], [http://www.ebi.ac.uk/pdbsum/4cjn PDBsum]</span></td></tr>
		+	</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	In the face of the clinical challenge posed by resistant bacteria, the present needs for novel classes of antibiotics are genuine. In silico docking and screening, followed by chemical synthesis of a library of quinazolinones, led to the discovery of (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one (compound 2) as an antibiotic effective in vivo against methicillin-resistant Staphylococcus aureus (MRSA). This antibiotic impairs cell-wall biosynthesis as documented by functional assays, showing binding of 2 to penicillin-binding protein (PBP) 2a. We document that the antibiotic also inhibits PBP1 of S. aureus, indicating a broad targeting of structurally similar PBPs by this antibiotic. This class of antibiotics holds promise in fighting MRSA infections.

-	~~The entry 4cjn is ON HOLD until Paper Publication~~	+	Discovery of Antibiotic (E)-3-(3-Carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one.,Bouley R, Kumarasiri M, Peng Z, Otero LH, Song W, Suckow MA, Schroeder VA, Wolter WR, Lastochkin E, Antunes NT, Pi H, Vakulenko S, Hermoso JA, Chang M, Mobashery S J Am Chem Soc. 2015 Feb 11;137(5):1738-41. doi: 10.1021/jacs.5b00056. Epub 2015, Feb 2. PMID:25629446<ref>PMID:25629446</ref>

-	~~Authors: Bouley~~, R.~~, Otero, L~~.~~H., Rojas-Altuve, A., Hermoso, J.A~~.	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-		+	</div>
-	~~Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand~~	+	== References ==
-	[[Category: ~~Unreleased Structures~~]]	+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Serine-type D-Ala-D-Ala carboxypeptidase]]
	[[Category: Bouley, R]]		[[Category: Bouley, R]]
-	[[Category: Hermoso, J.A]]	+	[[Category: Hermoso, J A]]
		+	[[Category: Otero, L H]]
	[[Category: Rojas-Altuve, A]]		[[Category: Rojas-Altuve, A]]
-	[[Category: ~~Otero, L.H~~]]	+	[[Category: Allosteric site]]
		+	[[Category: Hydrolase]]
		+	[[Category: Immune system]]

OCA at 13:20, 24 December 2014

OCA — Wed, 24 Dec 2014 13:20:08 GMT

←Older revision		Revision as of 13:20, 24 December 2014
Line 6:		Line 6:

	Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand		Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand
		+	[[Category: Unreleased Structures]]
		+	[[Category: Bouley, R]]
		+	[[Category: Hermoso, J.A]]
		+	[[Category: Rojas-Altuve, A]]
		+	[[Category: Otero, L.H]]

OCA at 06:05, 8 October 2014

OCA — Wed, 08 Oct 2014 06:05:23 GMT

←Older revision		Revision as of 06:05, 8 October 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4cjn is ON HOLD until ~~sometime in the future~~	+	The entry 4cjn is ON HOLD until Paper Publication

	Authors: Bouley, R., Otero, L.H., Rojas-Altuve, A., Hermoso, J.A.		Authors: Bouley, R., Otero, L.H., Rojas-Altuve, A., Hermoso, J.A.

	Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand		Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand

OCA at 22:45, 1 October 2014

OCA — Wed, 01 Oct 2014 22:45:32 GMT

←Older revision		Revision as of 22:45, 1 October 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4cjn is ON HOLD until ~~Paper Publication~~	+	The entry 4cjn is ON HOLD until sometime in the future

	Authors: Bouley, R., Otero, L.H., Rojas-Altuve, A., Hermoso, J.A.		Authors: Bouley, R., Otero, L.H., Rojas-Altuve, A., Hermoso, J.A.

	Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand		Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand

OCA at 06:44, 2 July 2014

OCA — Wed, 02 Jul 2014 06:44:59 GMT

←Older revision		Revision as of 06:44, 2 July 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4cjn is ON HOLD	+	The entry 4cjn is ON HOLD until Paper Publication

	Authors: Bouley, R., Otero, L.H., Rojas-Altuve, A., Hermoso, J.A.		Authors: Bouley, R., Otero, L.H., Rojas-Altuve, A., Hermoso, J.A.

	Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand		Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand

OCA at 05:34, 25 June 2014

OCA — Wed, 25 Jun 2014 05:34:32 GMT

←Older revision		Revision as of 05:34, 25 June 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4cjn is ON HOLD ~~until Paper Publication~~	+	The entry 4cjn is ON HOLD

	Authors: Bouley, R., Otero, L.H., Rojas-Altuve, A., Hermoso, J.A.		Authors: Bouley, R., Otero, L.H., Rojas-Altuve, A., Hermoso, J.A.

	Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand		Description: Crystal structure of PBP2a from MRSA in complex with quinazolinone ligand